This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Ghent. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Annelies Coddens: Innovator in Glycosphingolipid Research
Introduction
Annelies Coddens is a notable inventor based in Merelbeke, Belgium. She has made significant contributions to the field of glycosphingolipid research, particularly in relation to blood group determinants and their applications in veterinary medicine.
Latest Patents
Coddens holds a patent related to the blood group A/B/H determinant on Type 1 Core glycosphingolipid chains. This invention serves as a recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic bacteria. The patent outlines the use of compounds comprising such determinants for the treatment of F18 infections in pigs and in screening methods.
Career Highlights
Annelies Coddens is affiliated with the University of Ghent, where she conducts her research. Her work has been instrumental in advancing the understanding of glycosphingolipids and their implications in infectious diseases.
Collaborations
Coddens has collaborated with notable colleagues, including Eric Cox and Susann Eva Teneberg. These partnerships have enhanced her research and contributed to the development of innovative solutions in her field.
Conclusion
Annelies Coddens is a pioneering inventor whose work in glycosphingolipid research has the potential to impact veterinary medicine significantly. Her contributions continue to shape the landscape of scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
